用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

(版块PHARMACOLOGY & PHARMACY(药理学与药学)版块期刊总数:80)
新窗
投票 ESCI期刊Actualites Pharmaceutiques 2024/2025影响因子:0.124 (ACTUAL PHARMACEUT) (0515-3700). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:72; 2023 JIF:0.124; JIFRank: 352/354 ; Rank-JIF: 352; Number-of-JIF:354; 5 Year JIF:0.199; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.086; 2023 JCI:0.03; JCI Rank: 350/354 ; Total Articles:103; JCI Quartile:Q4; JCI Percentile:1.27; Eigenfactor:0; Normalized Eigenfactor:0.01; Article Influence Score:0.009; JIF Percentile:0.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:111; % of Articles in Citable items:0.9279; Cited Half-Life:NULL; Citing Half-Life:6.6; % of OA Gold:0.3524; Publisher name:INT MUSICOLOGICAL SOC; Publisher address:BOX 561, BASEL, SWITZERLAND, CH-4001;
投票 ESCI期刊SA Pharmaceutical Journal 2024/2025影响因子:0.284 (SA PHARM J) (2221-5875). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging  ...234
Total Citations:62; 2023 JIF:0.284; JIFRank: 350/354 ; Rank-JIF: 350; Number-of-JIF:354; 5 Year JIF:0.239; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:<0.1; Immediacy Index-dealt:0.083; 2023 JCI:0.01; JCI Rank: 354/354 ; Total Articles:7; JCI Quartile:Q4; JCI Percentile:0.14; Eigenfactor:0; Normalized Eigenfactor:0.009; Article Influence Score:0.039; JIF Percentile:1.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:32; % of Articles in Citable items:0.2188; Cited Half-Life:NULL; Citing Half-Life:7.3; % of OA Gold:0; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LANE, KIDLINGT
投票 ESCI期刊Asian Journal of Pharmaceutics 2024/2025影响因子:0.424 (ASIAN J PHARM) (0973-8398). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:712; 2023 JIF:0.424; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.553; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:<0.1; Immediacy Index-dealt:0.093; 2023 JCI:0.08; JCI Rank: 344/354 ; Total Articles:88; JCI Quartile:Q4; JCI Percentile:2.97; Eigenfactor:0; Normalized Eigenfactor:0.063; Article Influence Score:0.063; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:109; % of Articles in Citable items:0.8073; Cited Half-Life:6.8; Citing Half-Life:9.7; % of OA Gold:0.004; Publisher name:BENTHAM SCIENCE PUBL LTD; Publisher address:EXECUTIVE STE Y-2, PO BOX 7917, SAIF
投票 ESCI期刊Pharmacy 2024/2025影响因子:2.127 (PHARMACY-BASEL) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources Citation  ...234
Total Citations:2254; 2023 JIF:2.127; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:2.224; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.423; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:140; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.004; Normalized Eigenfactor:0.768; Article Influence Score:0.491; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:183; % of Articles in Citable items:0.765; Cited Half-Life:3.6; Citing Half-Life:6.9; % of OA Gold:0.9982; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE
投票 ESCI期刊CANADIAN JOURNAL OF HOSPITAL PHARMACY 2024/2025影响因子:0.605 (CAN J HOSP PHARM) (0008-4123). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:736; 2023 JIF:0.605; JIFRank: 326/354 ; Rank-JIF: 326; Number-of-JIF:354; 5 Year JIF:1.183; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.132; 2023 JCI:0.17; JCI Rank: 324/354 ; Total Articles:34; JCI Quartile:Q4; JCI Percentile:8.62; Eigenfactor:0; Normalized Eigenfactor:0.085; Article Influence Score:0.283; JIF Percentile:8.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:36; % of Articles in Citable items:0.9444; Cited Half-Life:8.3; Citing Half-Life:6.9; % of OA Gold:0; Publisher name:BMC; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 ESCI期刊JOURNAL OF PHARMACY TECHNOLOGY 2024/2025影响因子:1.192 (J PHARM TECHNOL) (8755-1225). (PHARMACOLOGY & PHARMACY)(药理学与药  ...234
Total Citations:422; 2023 JIF:1.192; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:1.415; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.1; Immediacy Index:0.1; Immediacy Index-dealt:0.147; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:39; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.118; Article Influence Score:0.355; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:50; % of Articles in Citable items:0.78; Cited Half-Life:5; Citing Half-Life:6.1; % of OA Gold:0.065; Publisher name:INT MEDICAL RESEARCH & DEVELOPMENT CORP; Publisher address:6308 12TH AVE, NEW YOR
投票 ESCI期刊Pharmaceutical Sciences 2024/2025影响因子:1.484 (PHARM SCI-IRAN) (1735-403X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emergi  ...234
Total Citations:584; 2023 JIF:1.484; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.254; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.5; Immediacy Index-dealt:0.577; 2023 JCI:0.47; JCI Rank: 250/354 ; Total Articles:37; JCI Quartile:Q3; JCI Percentile:29.52; Eigenfactor:0; Normalized Eigenfactor:0.084; Article Influence Score:0.164; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:48; % of Articles in Citable items:0.7708; Cited Half-Life:4.6; Citing Half-Life:8.1; % of OA Gold:0.9213; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MIL
投票 ESCI期刊Pharmaceutical Medicine 2024/2025影响因子:3.111 (PHARM MED) (1178-2595). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging So  ...234
Total Citations:453; 2023 JIF:3.111; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:2.424; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.8; Immediacy Index:0.9; Immediacy Index-dealt:0.976; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:30; JCI Quartile:Q2; JCI Percentile:61.72; Eigenfactor:0.001; Normalized Eigenfactor:0.186; Article Influence Score:0.68; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:44; % of Articles in Citable items:0.6818; Cited Half-Life:3.2; Citing Half-Life:6.9; % of OA Gold:0.4141; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE,
投票 ESCI期刊Journal of Pharmaceutical Health Care and Sciences 2024/2025影响因子:1.209 (J PHARM HEALTH CARE) (2055-0294). (PHARMA  ...234
Total Citations:400; 2023 JIF:1.209; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:1.412; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.2; Immediacy Index-dealt:0.289; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:48; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.112; Article Influence Score:0.36; JIF Percentile:18.2; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:50; % of Articles in Citable items:0.96; Cited Half-Life:4.7; Citing Half-Life:9.3; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Journal of Cannabis Research 2024/2025影响因子:4.172 (J CANNABIS RES) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emergi  ...234
Total Citations:615; 2023 JIF:4.172; JIFRank: 78/354 ; Rank-JIF: 78; Number-of-JIF:354; 5 Year JIF:3.875; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:1; Immediacy Index-dealt:1.141; 2023 JCI:0.97; JCI Rank: 88/354 ; Total Articles:32; JCI Quartile:Q1; JCI Percentile:75.28; Eigenfactor:0.001; Normalized Eigenfactor:0.241; Article Influence Score:0.869; JIF Percentile:78.1; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:35; % of Articles in Citable items:0.9143; Cited Half-Life:2.4; Citing Half-Life:5.6; % of OA Gold:1; Publisher name:AMER INST MATHEMATICAL SCIENCES-AIMS; Publisher address:PO BOX 2604, SPRINGFIELD, Unit
投票 ESCI期刊Annals of Phytomedicine-An International Journal 2024/2025影响因子:1.783 (ANN PHYTOMEDICINE) (2393-9885). (PHARMACOLO  ...234
Total Citations:1085; 2023 JIF:1.783; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.652; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:0.6; Immediacy Index-dealt:0.698; 2023 JCI:0.49; JCI Rank: 243/354 ; Total Articles:162; JCI Quartile:Q3; JCI Percentile:31.5; Eigenfactor:0; Normalized Eigenfactor:0.028; Article Influence Score:0.031; JIF Percentile:29.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:232; % of Articles in Citable items:0.6983; Cited Half-Life:2.3; Citing Half-Life:8.4; % of OA Gold:0.9965; Publisher name:OXFORD UNIV PRESS INC; Publisher address:JOURNALS DEPT, 2001 EVANS RD, CARY, U
投票 ESCI期刊Indonesian Journal of Pharmacy 2024/2025影响因子:0.782 (INDONES J PHARM) (2338-9486). (PHARMACOLOGY & PHARMACY)(药理学与药  ...234
Total Citations:249; 2023 JIF:0.782; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:0.713; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.158; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:44; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.031; Article Influence Score:0.082; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.9778; Cited Half-Life:4.6; Citing Half-Life:6.8; % of OA Gold:0.4014; Publisher name:EUROPEAN RESPIRATORY SOC JOURNALS LTD; Publisher address:442 GLOSSOP RD, SHEFFIEL
投票 ESCI期刊GaBI Journal-Generics and Biosimilars Initiative Journal 2024/2025影响因子:0.345 (GABI J) (2033-6403). (PHARMACOLOGY  ...234
Total Citations:75; 2023 JIF:0.345; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.684; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:NULL; Immediacy Index-dealt:NULL; 2023 JCI:0.16; JCI Rank: 327/354 ; Total Articles:0; JCI Quartile:Q4; JCI Percentile:7.77; Eigenfactor:0; Normalized Eigenfactor:2.978; Article Influence Score:0.844; JIF Percentile:3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:0; % of Articles in Citable items:NULL; Cited Half-Life:NULL; Citing Half-Life:NULL; % of OA Gold:0.0333; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Translational and Clinical Pharmacology 2024/2025影响因子:1.161 (TRANSL CLIN PHARMACO) (2289-0882). (PHARMACOLOGY & P  ...234
Total Citations:229; 2023 JIF:1.161; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.1; Immediacy Index:0.1; Immediacy Index-dealt:0.177; 2023 JCI:0.29; JCI Rank: 293/354 ; Total Articles:18; JCI Quartile:Q4; JCI Percentile:17.37; Eigenfactor:0; Normalized Eigenfactor:1.195; Article Influence Score:0.294; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:NULL; Citable Items:21; % of Articles in Citable items:0.8571; Cited Half-Life:4.5; Citing Half-Life:7.3; % of OA Gold:1; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTO
投票 ESCI期刊Journal of Dietary Supplements 2024/2025影响因子:1.906 (J DIET SUPPL) (1939-0211). (PHARMACOLOGY & PHARMACY)(药理学与药学)E  ...234
Total Citations:1229; 2023 JIF:1.906; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.9; Immediacy Index:0.6; Immediacy Index-dealt:0.632; 2023 JCI:0.52; JCI Rank: 227/354 ; Total Articles:21; JCI Quartile:Q3; JCI Percentile:36.02; Eigenfactor:0.001; Normalized Eigenfactor:0.053; Article Influence Score:0.081; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:NULL; Citable Items:27; % of Articles in Citable items:0.7778; Cited Half-Life:4.9; Citing Half-Life:8.4; % of OA Gold:0.2051; Publisher name:OXFORD UNIV PRESS; Publisher address:GREAT CLARENDON ST, OXFORD, ENGLAND
投票 ESCI期刊Journal of Reports in Pharmaceutical Sciences 2024/2025影响因子:0.779 (J REP PHARM SCI) (2322-1232). (PHARMACOLOGY &  ...234
Total Citations:175; 2023 JIF:0.779; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:0.7; Immediacy Index:NULL; Immediacy Index-dealt:NULL; 2023 JCI:0.15; JCI Rank: 329/354 ; Total Articles:0; JCI Quartile:Q4; JCI Percentile:7.2; Eigenfactor:0; Normalized Eigenfactor:0.081; Article Influence Score:0.375; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:NULL; Citable Items:0; % of Articles in Citable items:NULL; Cited Half-Life:4.3; Citing Half-Life:NULL; % of OA Gold:0; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA, CA, 91320;
投票 ESCI期刊PHARMACIA 2024/2025影响因子:1.145 (PHARMACIA) (0428-0296). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources Citation  ...234
Total Citations:445; 2023 JIF:1.145; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:1.105; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.2; Immediacy Index-dealt:0.213; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:104; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0; Normalized Eigenfactor:0.076; Article Influence Score:0.111; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:134; % of Articles in Citable items:0.7761; Cited Half-Life:2.5; Citing Half-Life:6.8; % of OA Gold:0.9508; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Pharmacoeconomics-Open 2024/2025影响因子:2.177 (PHARMACOECON-OPEN) (2509-4262). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emer  ...234
Total Citations:678; 2023 JIF:2.177; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:2.156; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.3; Immediacy Index-dealt:0.393; 2023 JCI:0.59; JCI Rank: 203/354 ; Total Articles:64; JCI Quartile:Q3; JCI Percentile:39.71; Eigenfactor:0.002; Normalized Eigenfactor:0.402; Article Influence Score:0.727; JIF Percentile:48; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:76; % of Articles in Citable items:0.8421; Cited Half-Life:3.4; Citing Half-Life:6.7; % of OA Gold:0.9804; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Advanced Pharmaceutical Bulletin 2024/2025影响因子:3.164 (ADV PHARM BULL) (2228-5881). (PHARMACOLOGY & PHARMACY)(药理学与  ...234
Total Citations:3318; 2023 JIF:3.164; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:4.386; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3; Immediacy Index:0.6; Immediacy Index-dealt:0.648; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:48; JCI Quartile:Q2; JCI Percentile:67.37; Eigenfactor:0.002; Normalized Eigenfactor:0.431; Article Influence Score:0.605; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:79; % of Articles in Citable items:0.6076; Cited Half-Life:5.7; Citing Half-Life:7.3; % of OA Gold:0.7983; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LANE
投票 ESCI期刊Egyptian Pharmaceutical Journal 2024/2025影响因子:0.738 (EGYPT PHARM J) (1687-4315). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:259; 2023 JIF:0.738; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:0.864; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.176; 2023 JCI:0.18; JCI Rank: 322/354 ; Total Articles:65; JCI Quartile:Q4; JCI Percentile:9.18; Eigenfactor:0; Normalized Eigenfactor:0.035; Article Influence Score:0.089; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:70; % of Articles in Citable items:0.9286; Cited Half-Life:4.3; Citing Half-Life:9.8; % of OA Gold:0; Publisher name:NULL; Publisher address:NULL;
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-16 13:16
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块